Cargando…
Personalized Diagnosis and Treatment for Neuroimaging in Depressive Disorders
Depressive disorders are highly heterogeneous in nature. Previous studies have not been useful for the clinical diagnosis and prediction of outcomes of major depressive disorder (MDD) at the individual level, although they provide many meaningful insights. To make inferences beyond group-level analy...
Autores principales: | Lee, Jongha, Chi, Suhyuk, Lee, Moon-Soo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9504356/ https://www.ncbi.nlm.nih.gov/pubmed/36143188 http://dx.doi.org/10.3390/jpm12091403 |
Ejemplares similares
-
Molecular Biomarkers for Pediatric Depressive Disorders: A Narrative Review
por: Lee, Jongha, et al.
Publicado: (2021) -
Personalized Medicine Using Neuroimmunological Biomarkers in Depressive Disorders
por: Chi, Suhyuk, et al.
Publicado: (2021) -
Impact of the COVID-19 Pandemic on Korean Adolescents' Mental Health and Lifestyle Factors
por: Lee, Jongha, et al.
Publicado: (2022) -
Neuroimaging Biomarkers for Predicting Treatment Response and Recurrence of Major Depressive Disorder
por: Kang, Seung-Gul, et al.
Publicado: (2020) -
Neuroimaging studies of depressive disorders in China since 2000
por: YIN, Yingying, et al.
Publicado: (2014)